MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$9,750,575
EPS
-$0.18
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development expenses
3,265,586
3,457,032
5,841,871.5*
4,576,389
General and administrative expenses
3,231,148
3,064,055
2,056,848*
3,563,753
Total operating expenses
6,496,734
6,521,087
7,898,719.5
8,140,142
Loss from operations
-6,496,734
-6,521,087
-7,898,719.5*
-8,140,142
Interest income
125,405
186,814
295,141.5*
281,109
Interest expense
3,379,246
1,014,783
396,318.5*
1,150,378
Interest income (expenses), net
-3,253,841
-827,969
-101,177*
-869,269
Loss before income taxes
-9,750,575
-7,349,056
-7,999,896.5*
-9,009,411
Benefit from income taxes
0
0
-1,169,820*
0
Net loss
-9,750,575
-7,349,056
-6,830,076.5
-9,009,411
Basic EPS
-0.18
-0.13
-0.147
-0.19
Diluted EPS
-0.18
-0.13
-0.147
-0.19
Basic Average Shares
55,659,669
55,496,279
46,380,807
46,869,531
Diluted Average Shares
55,659,669
55,496,279
46,380,807
46,869,531
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$9,750,575
(-3.35%↓ Y/Y)
Loss before income
taxes
-$9,750,575
(-3.35%↓ Y/Y)
Loss from operations
-$6,496,734
(14.78%↑ Y/Y)
Interest income
(expenses), net
-$3,253,841
(-79.69%↓ Y/Y)
Interest income
$125,405
(-62.41%↓ Y/Y)
Total operating
expenses
$6,496,734
(-14.78%↓ Y/Y)
Interest expense
$3,379,246
(57.58%↑ Y/Y)
Research and development
expenses
$3,265,586
(-22.49%↓ Y/Y)
General and
administrative expenses
$3,231,148
(-5.26%↓ Y/Y)
Buy us a coffee
PDS Biotechnology Corp (PDSB)
PDS Biotechnology Corp (PDSB)